| Fusobacteraeota| Fusobacteraeota Oren et al. 2015| Fusobacteria| Fusobacteria Garrity and Holt 2001| Fusobacteriota
Oral health: Fusobacteriota species are common inhabitants of the human oral cavity and are part of the oral microbiota. While they are typically commensal and play roles in normal oral microbial communities, certain species, such as Fusobacterium nucleatum, have been implicated in periodontal diseases. Fusobacterium nucleatum can contribute to the formation of dental plaque and biofilms, leading to periodontitis, gingivitis, and other oral health issues. Additionally, Fusobacterium species have been detected in dental abscesses and oral infections.
Systemic infections: Fusobacteriota species, particularly Fusobacterium necrophorum, have been associated with systemic infections such as Lemierre's syndrome. Lemierre's syndrome is a rare but serious condition characterized by septic thrombophlebitis of the internal jugular vein, often following an acute oropharyngeal infection. Fusobacterium necrophorum can spread from the oral cavity or pharynx to deeper tissues and the bloodstream, leading to septicemia and the formation of septic thrombi in the neck veins.
Inflammatory bowel disease (IBD): Emerging research suggests that Fusobacteriota species may play a role in the pathogenesis of inflammatory bowel diseases (IBD), including Crohn's disease and ulcerative colitis. While the exact mechanisms are not fully understood, Fusobacterium species have been detected in the gut mucosa of individuals with IBD, and their presence has been associated with intestinal inflammation and disease severity. However, the causal relationship between Fusobacteriota and IBD requires further investigation.
Colorectal cancer: Fusobacteriota, particularly Fusobacterium nucleatum, has been implicated in the development and progression of colorectal cancer (CRC). Studies have found an association between increased abundance of Fusobacterium nucleatum in colorectal tumors and poorer clinical outcomes in CRC patients. Fusobacterium nucleatum may promote tumorigenesis through various mechanisms, including modulation of the immune response, promotion of inflammation, and interaction with tumor cells. However, the exact role of Fusobacteriota in CRC pathogenesis is still being elucidated.
Other infections: Fusobacteriota species have been implicated in various other infections, including brain abscesses, septic arthritis, respiratory tract infections, and genital infections. Fusobacteriota may act as opportunistic pathogens, particularly in individuals with predisposing factors such as immunodeficiency, trauma, or underlying medical conditions.
A lot more information is available when you are logged in and raise the display level
Other Sources for more information:
Statistics | NCBI | Data Punk | End Products Produced |
Different labs use different software to read the sample. See this post for more details.
One lab may say you have none, another may say you have a lot! - This may be solely due to the software they are using to estimate.
We deem lab specific values using values from the KM method for each specific lab to be the most reliable.
Lab | Frequency | UD-Low | UD-High | KM Low | KM High | Lab Low | Lab High | Mean | Median | Standard Deviation | Box Plot Low | Box Plot High | KM Percentile Low | KM Percentile High |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Other Labs | 3.09 | 0 | 0 | 1 | 36917 | 0 | 16160 | 3099.2 | 470 | 6663.7 | 0 | 3180 | 0 %ile | 100 %ile |
biomesight | 47.95 | 0 | 30 | 10 | 220 | 0 | 34098 | 2541.9 | 40 | 16100.1 | 0 | 200 | 0 %ile | 92 %ile |
thorne | 100 | 45 | 596 | 0 | 394 | 154.1 | 114 | 122.5 | 38 | 270 | 0 %ile | 100 %ile | ||
thryve | 53.43 | 0 | 39 | 18 | 264 | 0 | 34172 | 2734 | 51 | 16039.8 | 0 | 211 | 10.9 %ile | 90.8 %ile |
ubiome | 18.38 | 0 | 23 | 20 | 233930 | 0 | 64244 | 8148.5 | 134 | 28620.2 | 0 | 2358 | 0 %ile | 100 %ile |
Source of Ranges | Low Boundary | High Boundary | Low Boundary %age | High Boundary %age |
---|---|---|---|---|
Medivere | 0 | 30 | 0 | 0.003 |
GanzImmun Diagostics | 0 | 40 | 0 | 0.004 |
Lab Teletest | 0 | 500 | 0 | 0.05 |
XenoGene | 0 | 10000 | 0 | 1 |
Thorne (20/80%ile) | 27.11 | 60.15 | 0.0027 | 0.006 |
Nirvana/CosmosId | 200 | 2500 | 0.02 | 0.25 |
Lab | Frequency Seen | Average | Standard Deviation | Sample Count | Lab Samples |
---|---|---|---|---|---|
AmericanGut | 13.333 % | 0.029 % | 0.032 % | 2.0 | 15 |
BiomeSight | 50.663 % | 0.281 % | 1.772 % | 1451.0 | 2864 |
BiomeSightRdp | 15.625 % | 0.002 % | 0.001 % | 5.0 | 32 |
bugspeak | 100 % | 0.01 % | % | 1.0 | 1 |
CerbaLab | 100 % | 0.042 % | 0.02 % | 3.0 | 3 |
CosmosId | 6.25 % | 0.009 % | 0.009 % | 2.0 | 32 |
custom | 52.542 % | 0.764 % | 0.785 % | 31.0 | 59 |
es-xenogene | 96.552 % | 0.117 % | 0.135 % | 28.0 | 29 |
GanzimmunDiag | 100 % | 0.009 % | 0 % | 3.0 | 3 |
Medivere | 85.714 % | 0.026 % | 0.037 % | 6.0 | 7 |
Microba | 10.714 % | 0.015 % | 0.002 % | 3.0 | 28 |
SequentiaBiotech | 19.444 % | 0.641 % | 1.349 % | 7.0 | 36 |
Thorne | 85.556 % | 0.011 % | 0.011 % | 77.0 | 90 |
Thryve | 53.29 % | 0.27 % | 1.61 % | 737.0 | 1383 |
Tiny | 100 % | 0.002 % | % | 1.0 | 1 |
uBiome | 18.308 % | 0.815 % | 2.862 % | 145.0 | 792 |
Click on Impact for information if high or low levels are causing the impact
Magnitude | Impact | Symptom |
---|
|
And display level must be raised above public.
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.